Publication Name	World Journal of Gastroenterology
Manuscript ID	33696
Country	Italy

Received	2017-02-27 10:30
Peer-Review Started	2017-02-27 21:54
To Make the First Decision	2017-04-07 17:19
Return for Revision	2017-04-07 17:27
Revised	2017-04-14 19:03
Second Decision	2017-05-18 03:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-05-19 08:00
Articles in Press	2017-05-19 08:00
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-06-22 03:59
Publish the Manuscript Online	2017-07-07 11:41

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
Manuscript Source	Invited Manuscript
All Author List	Francesca Romana Ponziani, Maria Assunta Zocco, Francesca D'Aversa, Maurizio Pompili and Antonio Gasbarrini
Funding Agency and Grant Number
Corresponding Author	Dr. Francesca R Ponziani MD, Division of Internal Medicine and Gastroenterology, Agostino Gemelli Hospital, largo Agostino Gemelli 8, 00168 Rome, Italy. francesca.ponziani@yahoo.it
Key Words	Intestinal bacteria; Antibiotic; Rifaximin; Gut microbiota; Eubiosis; Dysbiosis; Gut microbiota modulation
Core Tip	The traditional use of antibiotics in the clinical practice is to antagonize local or systemic infections. However, antibiotics induce several alterations of the gut microbiota, including the reduction of beneficial bacteria as well as of microbial diversity. Rifaximin is a non-absorbable antibiotic with broad-spectrum activity and non-traditional antimicrobial effects. Rifaximin has the potential to induce a positive modulation of the gut microbiota, favoring the growth of bacteria beneficial to the host without altering its overall composition. Therefore, rifaximin can be defined not only as an antibiotic but also as an “eubiotic”, namely a positive modulator of the gut ecosystem.
Publish Date	2017-07-07 11:41
Citation	Ponziani FR, Zocco MA, D’Aversa F, Pompili M, Gasbarrini A. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation. World J Gastroenterol 2017; 23(25): 4491-4499
URL	http://www.wjgnet.com/1007-9327/full/v23/i25/4491.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i25.4491

Full Article (PDF)	WJG-23-4491.pdf
Full Article (Word)	WJG-23-4491.doc
Manuscript File	33696-Review.docx
Answering Reviewers	33696-Answering reviewers.pdf
Audio Core Tip	33696-Audio core tip.aiff
Conflict-of-Interest Disclosure Form	33696-Conflict-of-interest statement.pdf
Copyright License Agreement	33696-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	33696-Language certificate.pdf
Peer-review Report	33696-Peer-review(s).pdf
Scientific Misconduct Check	33696-Scientific misconduct check.pdf
Scientific Editor Work List	33696-Scientific editor work list.pdf